The trademark DBNeuroRegen was filed by HIGHBRIDGE BIOMEDICAL CO.,LIMITED, a corporation established under the laws of the British Virgin Islands (the "Applicant"). The application was published for oppositions on October 27, 2021, and received one opposition filed on January 25, 2022 by PQ PARTNERS LIMITED on Likelihood of confusion. the opponent was represented by Vymazal, Tomáš and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 25, 2022
The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on October 20, 2021. Appointment and Replacement of representative of the trademark registration was recorded on May 25, 2022.
The Opposition with reference B 003162862 was refused according to Article 8(1)(b) EUTMR with decision issued on February 6, 2023 by the EUIPO.